---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-009743"
form_type: "8-K"
ticker: "INBS"
cik: "0001725430"
company_name: "INTELLIGENT BIO SOLUTIONS INC."
filed_at: "2024-03-13T23:59:59+00:00"
generated_at: "2026-06-04T22:26:10.639982+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# INBS raises $10.1M via private placement of common stock and warrants

## Summary
- Gross proceeds of ~$10.1M from sale of shares, pre-funded warrants, Series H-1 and H-2 warrants at $4.55/unit.
- Offering includes 2,223,333 shares, with warrants exercisable at $4.55; H-1 term 18 months post-SEC registration, H-2 five years reduced to 20 days after 510k clearance.
- Proceeds to fund working capital, clinical trials for Intelligent Fingerprinting Drug Screening System, and market expansion.
- Ladenburg Thalmann acted as exclusive placement agent; fees include 8% cash fee plus placement agent warrants at 125% of offering price.
- Registration rights agreement: file resale registration statement by March 18, 2024, effective by April 22, 2024.

## SEC filing metadata
- accession: 0001493152-24-009743
- form_type: 8-K
- ticker: INBS
- cik: 0001725430
- company_name: INTELLIGENT BIO SOLUTIONS INC.
- filed_at: 2024-03-13T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 1.01, 3.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1725430/000149315224009743/0001493152-24-009743-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1725430/000149315224009743/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-009743
- JSON: https://secwatch.observer/filing/0001493152-24-009743.json
- Plain text: https://secwatch.observer/filing/0001493152-24-009743.txt

## Key facts
- Material Agreements
  INTELLIGENT BIO SOLUTIONS INC. entered into Securities Purchase Agreement with several institutional and accredited investors (effective 2024-03-08).
  - Action: entry
  - Agreement: equity purchase
  - Counterparty: several institutional and accredited investors
  - Effective: 2024-03-08
  source text: On March 8, 2024, Intelligent Bio Solutions Inc. (the “Company”) entered into a Securities Purchase Agreement (the “Purchase Agreement”) with several institutional and accredited investors
  evidence_url: https://www.sec.gov/Archives/edgar/data/1725430/000149315224009743/0001493152-24-009743-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.